Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
InGeneron logo — Unlocking Regenerative Cell Therapy

InGeneron

Unlocking Regenerative Cell Therapy

Founded 2006 United States Houston, United States 18 employees Series Unknown Total: $52.75M Biotechnology, Health Care +1

General Information

Company Name InGeneron
Founded Year 2006
Location United States Houston, United States +1
Founders / Decision Makers
Team member
Employees 18
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Series Unknown
Social

Get notified when InGeneron moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About InGeneron

InGeneron is a clinical-stage biotechnology company that aims to revolutionize healthcare with its novel, safe, and evidence-based cell therapies. The company's mission revolves around unlocking the healing potential of each patient’s own regenerative cells processed at the point of care to enable same-day treatment, thus setting new therapeutic standards. Founded in 2006, InGeneron is currently focused on addressing orthopedic conditions and is actively engaged in multiple clinical trials to validate its technology as a disease-modifying treatment. With more than 20 years of research backing its work, InGeneron is committed to developing therapies supported by clinical evidence and approved by the FDA. Its recent $1.75M Venture Round investment on 01 March 2024 underscores investor confidence in the company's potential. As a company in the biotechnology and healthcare industries, InGeneron holds the promise to significantly impact the future landscape of regenerative medicine.

Taxonomy: Regenerative cell therapy, Clinical-stage biotechnology, Orthopedic conditions, Minimally invasive treatments, Cell therapy product platform, Stem and regenerative cell research, Autologous adult stem cells, FDA-approved therapies, Healthcare innovation, Point-of-care treatments

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 01 Mar 2024
Series D •••••• 1 •••• •••• 11 Jun 2019
Venture Round •••••• - 05 Apr 2019
Series D •••••• 1 •••• •••• 06 Mar 2017
Venture Round •••••• - 05 Oct 2015

InGeneron Alternatives & Competitors

InGeneron vs
CGT Global
CGT Global United States

Transforming healthcare by innovating treatment development and delivery.

75 employees
InGeneron vs
TC BioPharm
TC BioPharm United Kingdom

Treating cancer with γδ T cells | Nasdaq Ticker - $TCBP

Post Ipo Equity
51 employees
Biotechnology, Health Care
InGeneron vs
Cell BioEngines, Inc
Cell BioEngines, Inc United States

‘Off-the-Shelf’ Curative Cell Therapies

Pre Seed
3 employees
Biotechnology, Health and Wellness

FAQ About InGeneron

Unlocking Regenerative Cell Therapy
InGeneron was founded in 2006.
InGeneron is headquartered in Houston, United States.
InGeneron operates in the following industries: Biotechnology, Health Care, Health and Wellness.
InGeneron has approximately 18 employees.
InGeneron has completed 5 funding rounds, raising a total of $52.75M. The latest funding stage is Series Unknown.
Top alternatives and competitors to InGeneron include CGT Global, TC BioPharm , Cell BioEngines, Inc, Minerva Biotechnologies, Merakris Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
InGeneron and CGT Global are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors InGeneron and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy